Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 829 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Merz launches Mederma advanced scar gel

The transparent topical gel which contains Cepalin, the proprietary botanical extract derived from onions, is clinically shown to improve the texture, color, softness and overall appearance of scars.

Xeris wins US patent for Intracutaneous Injection

The new technology will enable biologics that are given as aqueous injections to be reformulated into a biocompatible, non-aqueous suspensions. The suspensions can be directly injected without reconstitution

Meda gains European approval for Astepro

The company expects to launch the nasal spray product in 2013. National registration processes, including price and reimbursement, will now follow in each country, the company said. Meda

Lexicon LX1032 drug wins FDA orphan drug status

Telotristat etiprate is an orally-delivered serotonin synthesis inhibitor (SSI) drug that acts to reduce serotonin levels. Lexicon chief medical officer and clinical development senior vice president Pablo Lapuerta